Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current RNAZ market cap is 353.62k. The company's latest EPS is USD -26.6376 and P/E is -0.02.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -457k | -726k | -6.15M | -18.67M | -19.42M |
| Net Income | -607k | -2.34M | -6.84M | -17.57M | -18.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 204k | 1.06M | 22.94M | 7.59M | 5.17M |
| Total Liabilities | 1.31M | 4.46M | 2.53M | 4.35M | 3.53M |
| Total Equity | -1.11M | -3.41M | 20.4M | 3.24M | 1.64M |
| Market Cap | 353.62k |
| Price to Earnings Ratio | -0.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.13 |
| Price to Book Ratio | 0.21 |
| Dividend Yield | - |
| Shares Outstanding | 696.23k |
| Average Volume (1 week) | 49.56M |
| Average Volume (1 Month) | 14.9M |
| 52 Week Change | -97.73% |
| 52 Week High | 66.33 |
| 52 Week Low | 0.491 |
| Spread (Intraday) | 0.02 (4.17%) |
| Company Name | TransCode Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.transcodetherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
